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Abstract
Although there is extensive information on gene expression and molecular interactions in various cell types, integrating
those data in a functionally coherent manner remains challenging. This study explores the premise that genes whose
expression at the mRNA level is correlated over diverse cell lines are likely to function together in a network of molecular
interactions. We previously derived expression-correlated gene clusters from the database of the NCI-60 human tumor cell
lines and associated each cluster with function categories of the Gene Ontology (GO) database. From a cluster rich in genes
associated with GO categories related to cell migration, we extracted 15 genes that were highly cross-correlated; prominent
among them were RRAS, AXL, ADAM9, FN14, and integrin-beta1. We then used those 15 genes as bait to identify other
correlated genes in the NCI-60 database. A survey of current literature disclosed, not only that many of the expression-
correlated genes engaged in molecular interactions related to migration, invasion, and metastasis, but that highly cross-
correlated subsets of those genes engaged in specific cell migration processes. We assembled this information in molecular
interaction maps (MIMs) that depict networks governing 3 cell migration processes: degradation of extracellular matrix,
production of transient focal complexes at the leading edge of the cell, and retraction of the rear part of the cell. Also
depicted are interactions controlling the release and effects of calcium ions, which may regulate migration in
a spaciotemporal manner in the cell. The MIMs and associated text comprise a detailed and integrated summary of
what is currently known or surmised about the role of the expression cross-correlated genes in molecular networks
governing those processes.
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Introduction
Although a great deal of information has accumulated on gene
expression and molecular interactions in various cell types, relating
those data to cell functions remains challenging. Here we ask
whether that relationship can be fruitfully probed on the basis of
gene expression profiles of a set of diverse human tumor cell lines.
Malignant cells often retain histological characteristics resembling
the tissue of origin, and tumor cell lines derived from the same
tissue of origin often retain similar gene expression patterns
[1,2,3]. Therefore groups of genes that are expressed specifically in
tumor cell lines from one or more tissues of origin may reflect
some aspect of the cells’ ‘‘life-styles’’. Cell lines having epithelial
versus mesenchymal characteristics, for example, have gene
expression patterns that tend to correspond to those respective
tissue types (reference [4] and K. W. Kohn and B. R. Zeeberg
unpublished data). Mutations and genome scrambling in malig-
nant tumors, however, can cause gene expression patterns to
diverge substantially among different cell lines of a given tissue
type.
The NCI-60 are a set of 60 human tumor cell lines derived from
various tissues of origin. Expression of approximately 16,000 genes
in each of those cell lines has been assayed and subjected to
bioinformatic analyses [3,5,6,7,8]. We recently developed a pro-
cedure that generated gene clusters based on NCI-60 gene
expression profiles and that associated the gene clusters with sets of
function categories defined by the Gene Ontology (GO) database
[9]. We focus here on one of those clusters (cluster 52/160), which
was rich in genes associated with GO categories related to cell
migration.
The ability to migrate and invade normal tissues inappropriately
is one of the features that tumor cells must acquire to become fully
malignant [10]. The mobility of malignant tumor cells depends on
complex molecular interactions that regulate the structure,
function, and interactions of cytoskeleton and extracellular matrix
[11]. Here we describe an expression-correlated set of genes that
function in molecular interaction networks promoting cell
migration through extracellular matrix degradation and calcium
signaling. We depict the networks using our notation for molecular
interaction maps [12,13]. The results organize the available
current information about those processes and suggest new
viewpoints, as well as new functional relationships for investiga-
tion. To our knowledge, this is the most detailed description and
mapping so far reported of molecular interaction networks linked
to gene expression data relevant to mammalian cell migration.
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CellMiner, cluster analysis, and derivations
The mRNA expression data for the NCI-60 human tumor cell
lines were retrieved from CellMiner relational database version 1.0
[14], which will become freely available (contact William
Reinhold: wcr@mail.nih.gov). The database contains transcript
expression values for several assays of the 60 cell lines, which are
normalized to generate expression profiles called ‘‘z-scores.’’ Gene
transcript expression values were used as described by Zeeberg
et al. [9].
The genes studied in the current work were based on an NCI-60
gene expression cluster,designated cluster 52/160, that was
identified by Zeeberg et al. [9]. In brief, gene clusters based on
expression in the NCI-60 cell lines were derived at 4 levels of
resolution (20, 40, 80, and 160 clusters) such that a cluster in the
160 level, for example, was a ‘‘child’’ (and therefore a subset) of
some cluster in the 80 level. The 300 gene lists corresponding to
each cluster were then submitted to the High-Throughput
GoMiner (HTGM) program [15] to determine the corresponding
Gene Ontology (GO) [16,17] functional categories. The current
work investigates one of the highest resolution clusters (designated
cluster 52/160 – cluster 52 of the 160 level), a cluster associated
with GO categories, many of which are related to cell adhesion
and migration (Figure 1).
High cross-correlation set (HCCS) genes
From the 83 genes in cluster 52/160, we found 15 genes
(‘‘HCCS15’’, Figure 2) that were highly cross-correlated with each
other. HCCS15 is the set of all cluster 52/160 genes such that the
expression profile of each gene was correlated with all the other
genes in the set, the required pair-wise correlation between
expression profiles being .0.50 (corresponding approximately to
P,0.001) (a rare value between 0.47 and 0.50 was permitted).
Those 15 genes were then used as seeds to find other genes with
similar expression profiles across the NCI-60 cell lines (NCI’s
CellMiner software, under development). The resulting set of 66
high cross-correlated genes (‘‘HCCS66’’, Figure S1) contains 51
additional genes selecte on the basis of correlation with all of the
original HCCS15 genes, such that all expression profile correla-
tions were greater than 0.40 and that at least 11 expression profile
correlations were .0.50, and further that average expression
profile correlation over the entire set of 66 other genes in HCCS66
was .0.50. (Many of the additional 51 genes met correlation
criteria that might have included them in cluster 52/160, but the
clustering algorithm, which assigned each gene to only one cluster,
assigned them to other clusters with which they were at least as
well correlated [9]).
Literature survey
PubMed literature surveys for relevant genes focused on the
most recent publications of new findings and reviews. In order to
keep the reference list as short and relevant as possible, recent
articles were often cited that contained references to the original
work. In those rare instances of substantial divergence of reports,
we accepted the inferences when recent reports indicated
a consensus of opinion. The PubMed searches included alternative
names of the genes or gene products. We generally use the HUGO
Gene Nomenclature Committee (HGNC) names for genes [18],
although we sometimes used common names for the expressed
proteins. It was often useful to search for papers dealing with
a combination of two genes or gene products to look for data
indicating interactions between the two. We used direct literature
surveys rather than indirect literature search software in order to
obtain the most detailed and up-to-date information. Sometimes
gene pairs having highly correlated expression profiles were not
mentioned together in any publication, suggesting that future
studies may disclose new pathways involving those gene pairs.
Molecular interaction maps (MIM)
Molecular interaction maps (MIMs) were created using
a Pathvisio-based tool recently developed in our Laboratory to
assist drawing MIM-type diagrams [19]. The symbols and rules of
the MIM notation are described in [13] and at http://discover.
nci.nih.gov/mim/. The molecular interactions in the MIM
diagrams are numbered for reference in the text.
Our MIMs are intended to show the interactions that would
occur when the relevant molecular species are present at the same
time and place. Expression and localization must therefore be
taken into account in applying MIMs to particular biological
situations.
Results
In order to select a group of genes that are likely to engage in
molecular interactions leading to a particular function, we began
with the 83 genes that constitute cluster 52/160 of Zeeberg et al
[9], derived on the basis of similarity of gene expression profile
across the NCI-60 cell lines. This set of genes mapped to many
GO categories related to cell migration, as well as to categories
related to other functions (Figure 1). We used the genes in
cluster 52/160 as a vehicle for assembly of expression-correlated
genes that co-function in molecular interaction networks de-
scribing particular aspects of cell migration control.
From cluster 52/160, we selected 15 genes (HCCS15) whose
expression profiles across the NCI-60 cell lines were highly cross-
correlated with each other (Figure 2). The criterion for inclusion in
HCCS15 was that each gene have expression profile correlation of
at least 0.50 with respect to every other gene in the set. To this set
of 15 genes, an additional 51 were added on the basis of highly
correlated expression in the NCI-60 cell lines, as described under
Methods. The data for the complete set of 66 genes (HCCS66) are
presented as a clustered image map (CIM) (Figure S1). For most of
these 66 genes, survey of current literature disclosed evidence of
molecular interactions related to some aspect of cell migration or
invasion, including (1) integrin and cytoskeleton-targeted actions of
RRAS and calcium; (2) degradation and remodeling of extracel-
lular matrix; (3) retraction of the rear of a migrating cell; (4)
connections and remodelling between integrins and actin
cytoskeleton; (5) role of endocytosis of cell surface receptors; and
(6) role of proteoglycans in extracellular matrix. The current
report focuses on the first three of these. Among the 66 genes in
the cross-correlated set HCCS66, we found 24 that had functions
related to the 3 aspects of cell migration covered by this report.
These 24 genes (HCCS24) are listed above the blue line in
Figure 3, together with their pair-wise expression profile correla-
tions, and will appear in red in the molecular interaction maps.
Data for an additional 8 interacting genes, derived from the
literature survey, are listed below the horizontal blue line in
Figure 3; the cross-correlations for these 8 genes were not
sufficiently high to be included in HCCS66 or HCCS24. A
clustered image map (CIM) of the relative expression of the 32
genes in each of the NCI-60 cell lines is shown in Figure 4, and
a gene correlation CIM is shown in Figure 5.
Gene Expression and Molecular Interactions
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e35716Figure 1. Gene Ontology (GO) categories associated with the 83 genes in cluster 52/160 (see Methods).
doi:10.1371/journal.pone.0035716.g001
Figure 2. High cross-correlation set of 15 genes (HCCS15) derived from cluster 52/160. The genes marked with an asterisk (*) are
discussed in the current report and are included in the molecular interaction maps (Figures 11 and 12). The other genes in the table function in other
aspects of cell migration that are not covered in the present report. The numbers in the table are expression profile correlations for expression of
gene pairs in the NCI-60 human tumor cell lines (expression profile correlation .0.50 corresponds approximately to P,0.001; expression profile
correlations .0.60 are almost never due to chance alone).
doi:10.1371/journal.pone.0035716.g002
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e35716Figure 3. Expression profile cross-correlations of the 32 genes that participate in the interaction networks shown as molecular
interaction maps in Figures 11 and 12. The right-most column lists the averages for each row. Above the horizontal line are 24 genes (HCCS24)
that had expression profile cross-correlation averages greater than 0.50; these 24 genes are shown in red in Figures 11 and 12. Genes marked with an
asterisk (*) were also in the HCCS15 gene set (Figure 1). Below the lines are genes that, although they participate in the networks shown in Figures 11
and 12, had expression profile correlations too low to be included in HCCS66 or HCCS24; these genes are shown in black in Figures 11 and 12.
(Individual expression profile correlations .0.30 were considered significant.)
doi:10.1371/journal.pone.0035716.g003
Figure 4. Clustered image map (CIM) of the relative expression of the 32 genes in Figure 3 in each of the NCI-60 cell lines. In addition,
the CIM includes CDH1 (E-cadherin, a marker genes for epithelial character) and VIM (vimentin, a marker genes for mesenchymal character). The CIM
image (Euclidean norm, complete linkage) was computed using custom in-house R language code. The genes below the blue line are the 24 genes in
high cross-correlation set HCCS24 (above the blue line in Figure 3 and marked red in Figures 11 and 12 ). Genes that were also in HCCS15 (Figure 2)
are highlighted in yellow. The vertical red lines help to discern which cell lines of a given tissue type cluster together, which deviate, and which fall
into a cluster dominated by a different tissue type. The arrow points to ovarian carcinoma cell line OVCAR4, which was unusual in showing high
expression of both CDH1 and VCL.
doi:10.1371/journal.pone.0035716.g004
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e35716Figure 5. Correlation CIM of the same genes as in Figure 4. The genes in the blue box are the 24 high cross-correlation HCCS24 genes; these
genes correlated significantly with VIM and not with CDH1, showing that they correlate with mesenchymal character. Note however that some genes
correlated better than others with VIM: genes such as RAC1 and GAS6, as well as VIM, which failed to meet the strict criteria for inclusion with the
HCCS24 genes, nevertheless are seen to be significantly correlated with them. Interestingly, some of the genes that were imperfectly correlated with
the HCCS24 genes (i.e., GAS6, MAPK8, YAP1, and RAC1) tend to correlate inversely with VIM; the cell lines that contribute to this effect can be seen in
Figure 4 (they include 4 colon lines that express CDH1 but not VIM). The low correlation of FURIN with the HCCS24 genes is attributable to its
functioning in stromal rather than tumor cells (Figure 12); the low correlation of FAM38A however remains unexplained.
doi:10.1371/journal.pone.0035716.g005
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integrins and actin cytoskeleton
Having assembled the subset of 15 high cross-correlated genes
(HCCS15) from the 83 genes of cluster 52/160, we noted that the
expression profile correlation (0.78) between RRAS and ITGB1
(beta1-integrin) was among the highest we had seen (Figure 2).
Although RRAS and ITGB1 did not at first seem functionally
related, a recent report showed how they may function together in
a well-defined network [20]. We found that report by a literature
search only after having observed the unexpected high expression
correlation. That encouraged us to pursue the premise that
mRNA expression correlations in the NCI-60 cell lines can predict
functional relationships. The expression profiles of several key
genes are shown in figures 6 and 7.
ITGB1 and RRAS were highly expressed in all of the renal and
most of the lung cancer cell lines, and both genes were expressed
at relatively low or undetectable levels in all of the leukemia and
most of the melanoma cell lines (Figure 6A). The NCI-60 data
show that every cell line that expressed ITGB1 also expressed
RRAS. When ITGB1 is expressed, therefore, an RRAS-de-
pendent process to regulate its function may commonly be in
place. Of 27 lines that showed substantial RRAS expression,
T47D was the only one that failed to express ITGB1 (Figure 6A).
Therefore, regulation of ITGB1 could be an important RRAS
function.
The mechanism proposed by McHugh et al [20] is portrayed as
a molecular interaction map (MIM) in Figure 8. (MIM symbols are
summarized in Figure 9.) In their proposal, Fam38A recruits
activated RRAS to the endoplasmic reticulum (ER) (interaction 1)
and causes Ca (2
+) release from the ER (interaction 2). The increased
cytosolic Ca (2
+) then activates Calpain to cleave Talin (interaction
3), thereby disrupting the linkage between integrins and the actin
cytoskeleton (interactions 4 and 5). Consequently, the stable linkage
between integrin and extracellular matrix (ECM), which is
dependent on inside-out-signaling [11] (interaction 6), is lost.
The model was supported by the finding that tight linkage
between integrin and extracellular matrix (ECM) was blocked by
inhibiting Fam38A, RRAS, or Talin [20]. Also consistent with the
Figure 6. Relative gene expressions for the NCI-60 human tumor cell lines. Bars to the right show increased expression, bars to the left
show decreased expression relative to the expression mean. Each panel shows the lowest, highest and mean expression levels (numbers at the lower
left from top to bottom). Expression values are normalized as z-scores (see Methods). The horizontal axes are marked in standard deviations from the
mean. (A) Expression profiles for RRAS, ITGB1, and CAPN2. (B) Expression profiles for ADAM9, AXL, and TNFRSF12A. (C) Epithelial and mesenchymal
gene expression profiles, indicated by CDH1 (E-cadherin) and VIM (vimentin) respectively, showing their inverse relationships. (D) Comparison of
expression profile of migration-related genes, represented by AXL, with that of mesenchymal-related genes, represented by VIM and SNAI2 (Slug).
doi:10.1371/journal.pone.0035716.g006
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e35716Figure 7. Expression of AXL and its ligand GAS6. (A) Expression level (z-score) of each cell line. (B) Number of cell lines that express AXL, GAS6,
both, or neither. (C) Cell lines that strongly express both AXL and GAS6, suggestive of a possible autocrine mechanism.
doi:10.1371/journal.pone.0035716.g007
Figure 8. Molecular interaction map (MIM) of the role of RRAS and calcium in the regulation of linkage between integrins and actin
cytoskeleton, as proposed by McHugh et al [20]. ECM, extracellular matrix.
doi:10.1371/journal.pone.0035716.g008
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freed from ECM attachment, was RRAS-dependent [21], and that
epithelial cell migration requires RRAS [22]. This pathway may
be regulated by activation/inactivation of RRAS, the mechanism
of which remains to be elucidated.
We then looked to see whether the NCI-60 expression profiles
implicated Fam38A, or any of the calpains or talins. Among those
genes, CAPN2 (calpain-2) gene expression stood out in being
strongly correlated with the HCCS15 genes (Figures 3 and 6A).
CAPN2 was not in the original cluster 52/160 only because the
clustering algorithm assigned it to another gene cluster where its
correlations were at least as good [9]. Of the other calpains, only
CAPNS1, which co-functions with CAPN2, showed high correla-
tions (Figure 10). Neither Fam38A nor any of the talins showed
high correlation. We infer therefore that CAPN2 is probably the
calpain that operates in the RRAS-ITGB1 pathway proposed by
McHugh et al [20]. CAPN2 is activated at relatively high Ca (2
+)
concentrations (0.4–0.8 mM) and is thought to cleave focal
adhesion components to facilitate rear retraction [23].
We then extended the McHugh et al model by adding relevant
genes from the high cross-correlation gene set HCCS66, as shown
in the MIM in Figure 11; the interactions and functions for each
gene are summarized below. Note that all of the HCCS24 genes in
Figure 11 (red), with the exception of TRPC1, are included in the
same gene cluster in the expression CIM (Figure 5, blue box).
RRAS participates in multiple functions, several of which are
relevant to the regulation of integrin-cytoskeleton linkage and
which are depicted in Figure 11. RRAS regulates cell migration
and adhesion, although the effects may be stimulatory or
inhibitory, apparently depending on cell type or conditions [24].
RRAS can promote cell migration by activating RAC1 through
stimulation of a guanine nucleotide exchange factor (GEF)
(Figure 11, interaction 1). This may be mediated through RRAS
binding and activating phosphatidylinositol-3–kinase (PI3K), since
a PI3K inhibitor (LY294002) inhibited RRAS-induced RAC1
activation [25]. RRAS binds FLNA (filamin A) (interaction 2), and
this combination was required for migration of melanoma cells
[26] (see section below on FLNA).
Cell migration and spreading due to activation of RAC1 by
RRAS is dependent on RALBP1/RLIP76 (interaction 3) [27].
However, RALBP1 is also a GTPase activating protein (GAP) that
inactivates RAC1 by converting the GTP to the GDP form
(interaction 4) [28]. The latter effect may seem contradictory, but
may reflect a cyclic process of cell attachment/detachment from
ECM.
TRPC1, a HCCS15 gene (Figure 2), is a component of calcium
channels in the plasma membrane that are activated by depletion
of calcium stores in the endoplasmic reticulum (ER) [29–30]
(interactions 5–7). ER calcium concentration is sensed by STIM1,
which activates TRPC1 when ER calcium concentration is low
[31]). TRPC1 forms heterodimers with other TRPC’s to constitute
store-dependent cation channels. However none of the other
TRPC genes were well correlated with HCCS genes. The high
expression correlation between TRPC1 and RRAS within the
HCCS (zscore=0.62, Figure 2) suggests that these 2 genes
function in concert to regulate calcium concentration in migrating
cells, i.e., RRAS permitting calcium release from endoplasmic
reticulum and TRPC1 allowing calcium entry into the cell if
endoplasmic reticulum calcium is depleted. The combination of
transient calcium release from endoplasmic reticulum and calcium
entry through plasma membrane pores might produce calcium
flickers (duration of a few seconds or less) near the leading edge of
a migrating cell [23]. In addition, the migrating cell exhibits a more
persistent and spacially extended calcium gradient increasing from
front to rear. The possible role of RRAS-FAM38A-TRPC1 in
these calcium patterns remains to be elucidated.
FLNA (filamin A), was not a member of the HCCS15 genes, but
correlated strongly with those genes, and was in the extended set
HCCS24 of highly cross-correlated genes represented in the
molecular interactions map in Figure 11. FLNA promotes cell
motility and migration, binds beta-integrin tails, and associates
and co-localizes with RRAS [26]. FLNA also binds non-muscle
Figure 9. Essential molecular interaction map (MIM) symbols. For detailed descriptions of the MIM notation, see [13] or http://discover.nci.
nih.gov/mim/mim_pathvisio.html
doi:10.1371/journal.pone.0035716.g009
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(Figure 11, interactions 2, 8, and 9). FLNA and RRAS are required
for migration of at least some cell types [26]. The RRAS-FLNA
combination can increase the fibronectin-binding affinity of
integrins and enhance fibronectin matrix assembly [26] (interaction
10). Additionally, endocytosis of ITGB1 from ruffles was recently
found to be RRAS-dependent [21] (interaction 11).
Where FLNA is abundant RRAS thus may enhance integrin
attachment to ECM, whereas in regions of the cell where FLNA is
lacking RRAS may stimulate calcium release and abrogate those
attachments. This may implement the dynamic attachment to and
release from ECM at local regions of the cell surface, which is
required for cell mobility (see Discussion).
TRIO, a member of the HCCS24 gene set (Figures 3, genes
above the blue line), is a guanine nucleotide exchange factor (GEF)
that activates RAC1 (Figure 11, interaction 12) and stimulates the
invasive behavior of some glioblastoma and breast cancers;
inhibitors of this action of TRIO have been developed [32–33].
RAC1, as well as RRAS, may also be activated indirectly by way
of HCCS24 gene BCAR3 (interactions 13 and 14) [34].
VCL (vinculin) is one of the 15 genes in the original high cross-
correlation set HCCS15 (Figure 2). It is a key component of the
chain connecting integrins with F-action, most prominently
connecting to integrin via talin (Figure 11). Although a great deal
of information has been reported about the structure and function
of VCL, much remains to be learned about its complex
interactions in various locations and under various circumstances
[35].
Modulation of interactions between extracellular matrix
and the surface of migrating cells
In order to migrate, cells must sequentially connect and
disconnect cell surface regions from extracellular matrix (ECM)
[36]. Release from ECM may occur through dissolving the
connections between binding domains or through degrading or
sequestering components of the ECM or cell surface proteins. In
some tumor cells, ECM degradation or remodeling is required for
the mobility to invade and metastasize [37]. Here we describe how
the 4 most highly cross-correlated HCCS15 genes (ADAM9,
AXL, ITGB1, and TNFRSF12A/FN14) (Figure 2), as well as
some related genes, may function coherently to modulate the
binding between ECM and the cell surface (Figure 12).
ADAM9 encodes an integral membrane protein, located at the
basolateral surface of epithelial cells, that promotes degradation of
the basement membrane, thereby facilitating cell migration and
invasion [38]. It is a metalloproteinase with domains mediating
cell-cell and cell-matrix interactions. In addition, it is a major
sheddase that releases integrins, as well as EGFR ligand NRG1b,
from its membrane-bound precursor into the extracellular
medium [39–40]. The chromosomal region of ADAM9 (8p11–
12) is amplified in some breast cancer tumors and cell lines. Over-
expression of secreted short isoform ADAM9S enhances cell
migration, whereas expression of full length ADAM9 tends to
reduce cell migration [38].
ADAM9 is widely expressed in mammalian tissues, including
stem cells [41], is found in all components of the nephron, and
interacts with beta-1 integrins at the basolateral surfaces of cells
[39]. It is highly expressed in a large fraction of renal cell cancers,
as well as other solid tumors, and is associated with metastases and
unfavorable prognosis [42] [41]. In accord with those reports,
ADAM9 was strongly expressed in 7 of the 8 NCI-60 renal cancer
cell lines (Figure 6B).
ADAM9, or secreted isoform ADAM9S, can cleave ECM
proteins directly (Figure 12, interactions 1 and 8), and can bind
ITGB1 (integrin beta-1) on either the same or on an adjacent cell
(interactions 2 and 7). Additionally, they can induce the expression of
matrix metalloproteinases, such as MMP9, which is secreted into
the ECM [43]. MMP9 expression requires the Ras-Raf-Erk
pathway, which may be activated by the ADAM9-integrin
combination, either in the same cell (interactions 3a and 4a)o ri n
an adjacent cell (interactions 3b and 4b). Expression may be further
enhanced by transcription factors such as NFkB [37] (interaction 5).
MMP9 (or other MMPs) then degrade collagen and other ECM
proteins, including HCCS66 gene product COL4A1 (interaction 6).
Both the direct and MMP-mediated protease activities may
facilitate cell migration [43].
Figure 10. Expression profile correlations of calpain family genes and key genes the HCCS15 high cross-correlation subset.
Expression data for CAPN4 and CAPN11 were not available. CAPNS1 is known to function together with CAPN2.
doi:10.1371/journal.pone.0035716.g010
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assays, and the protease activity of ADAM9S is required for this
effect [44]. ADAM9S secreted by tumor cells may bind integrins
on neighboring stromal cells, which rather than the tumor cells
themselves may be responsible for most of the protease-induced
cleavage of ECM proteins [44]. Up-regulation of ADAM9S may
favor separation of adjacent cells and remodeling of ECM. That
this may be a key role of ADAM9 in regulating cell migration is
consistent with ADAM9 being near the top of the HCCS15 high
cross-correlation list (Figure 2).
AXL encodes a receptor tyrosine kinase that can be activated by
its secreted ligand, GAS6 [45] (Figure 12, interaction 9). AXL can
bind a variety of intracellular signaling molecules, including PI3K
and Grb2. More important however may be its ability to activate
the Ras-Raf-Erk pathway leading to induction and secretion of
MMP9 (interaction 10). This induction is coordinated with NFkB,
which is GAS6-independent. MMP9-induction by AXL enhances
the invasive capability of tumor cells [37] [46]. Thus, suppression
of AXL (by means of shAXL) suppressed the level of MMP9
mRNA [47].
ADAM9 and AXL thus may both input to the Ras-Raf-Erk
pathway leading to induction and secretion of MMPs such as
MMP9. At least in the case of ADAM9, this may be induced by an
inter-cellular interaction that stimulates the pathway in an
adjacent stromal cell (‘‘by-stander effect’’); stromal fibroblasts are
often intimately associated with cancer cells and can form tight
junctions and paracrine interactions with them [48,49].
AXL is often expressed together with GAS6 in a variety of
human cancers, often being highly expressed in advanced stage
human breast and ovarian cancer [50]. High AXL expression in
breast cancer is associated with reduced survival [51], and
suppression of AXL prevented the initiation of ovarian metastases
Figure 11. MIM of the role of RRAS and calcium in the regulation of linkage between integrins and actin cytoskeleton, including
participation of relevant genes from the HCCS66 gene set. HCCS66 genes are colored red; those from the original HCCS15 set are also
marked with an asterisk. The interactions of Fam38A and CAPN2 are described in Figure 8 and related text. ER, endoplasmic reticulum. (MIM symbol
definitions are summarized in Figure 9.)
doi:10.1371/journal.pone.0035716.g011
Gene Expression and Molecular Interactions
PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e35716in mice [47]; AXL gene expression was moderate to high in 4 of
the 7 NCI-60 ovarian cancer lines (Figure 6B).
The stimulation of cell invasiveness by AXL is at least in part
mediated via matrix metalloproteinases; AXL-induced cell
migration required MMP9, and suppression of AXL (by means
of shAXL) suppressed the level of MMP9 mRNA [47].
Although GAS6 did not correlate well in overall gene expression
with the HCCS genes, GAS6 and AXL nevertheless were strongly
expressed together in several of the NCI-60 cell lines (Figure 7A).
Most cell lines expressed both AXL and GAS6 at significant levels
or expressed neither gene significantly (Figure 7B). An autocrine
mechanism, as previously noted in metastatic cancers [51], may
Figure 12. MIM of the role of ADAM9, AXL, ITGB1, TNFRSF12A/FN14 and functionally related genes/proteins in extracellular matrix
(ECM) degradation or remodeling. HCCS66 genes are colored red; those that were also in the original HCCS15 set are marked with an asterisk.
(MIM symbol definitions are summarized in Figure 9.)
doi:10.1371/journal.pone.0035716.g012
Gene Expression and Molecular Interactions
PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e35716therefore be operating particularly in those cell lines that expressed
both genes at high levels (Figure 7C).
Activation of overexpressed AXL can cause cell aggregation,
which suggests that AXL may engage in homophilic interactions
between neighboring cells (Figure 11, interaction 9a). The cell
adhesion effect of AXL appears to be ligand-independent and does
not require the intracellular domain; this binding may contribute
to the ability of cells to metastasize [52].
TNFRSF12A encodes FN14 (Figure 12, interaction 11), a type I
membrane protein. It is a receptor for TWEAK (interaction 12),
a type II membrane protein located at cell-cell junctions [53].
FGF2, a HCCS24 gene (Figure 3), enhances the expression of
TNFRSF12A [54] (interaction 13). It also mediates TWEAK-
induced NFkB activity, which enhances the expression of MMP9
[53,55] (interaction 14).
TNFSF12, the gene that codes for TWEAK (interaction 15), is
induced in injured tissues and in stroma associated with tumors;
increased levels of TWEAK have been found in several types of
solid tumors [53]. A secreted form of TWEAK may be generated
by proteolyic cleavage, perhaps by Furin convetase (interaction 16).
Furin is over-expressed in colon, head and neck, and ovarian
cancers, and over-expression in ovarian cancer correlated with
decreased survival [56]. There was no significant correlation
between Furin or TNFSF12 and cell migration-related NCI-60
genes, perhaps because Furin and TNFSF12 act in adjacent
stromal rather than in tumor cells.
The interaction of TWEAK with FN14 in cells of the central
nervous system increases the permeability of the blood-brain
barrier, probably due to degradation of extracellular matrix
components by MMP9 [57]. The TWEAK-FN14-induced
activation of the NFkB pathway mediates hypoxia-induced
neuronal cell death and PARP accumulation in vitro and in vivo
[58].
The strongly correlated expression profiles of ADAM9 and
TNFRSF12A (Figures 2 and 6B) suggests that ADAM9 may
directly or indirectly cleave TWEAK on adjacent cells and release
the truncated product from the membrane, making it available for
binding to its receptor, TNFRSF12A/FN14. This conjecture is
included in the molecular interaction model shown in Figure 12
(interaction 17).
Thus the coherent functions of ADAM9, AXL, and
TNFRSF12A are remarkably consistent with their highly cross-
correlated gene expressions in the NCI-60 cell lines (expression
profile correlations 0.67–0.81, Figure 2). The relevant focus of
action of these genes/gene products is degradation of extracellular
matrix via metalloproteinases, and, interestingly, these 3 genes
share the ability to engage in bindings between adjacent cells. To
our knowledge, the functional relationship among these genes has
not previously been reported.
The cell lines exhibiting the strongest co-expression of ADAM9,
TNFRSF12A, and AXL were 2 ovarian cancer lines (OVCAR_8
and SK_OV_3), lung cancer line HOP_92, and several renal
cancer lines, suggesting that these cell lines may be particularly
active in degrading extracellular matrix. These cell lines may be
suitable for investigation of the function relationships of these
genes.
ITGB1, a prominent HCCS15 gene, together with ITGA3,
which is a prominent HCCS24 gene (Figure 3), generate an
integrin heterodimer that links the cell surface to ECM structures
such as focal adhesions [59] (Figure 12, interaction 18). Dynamic
local binding and release of integrins from ECM proteins is
required for cells to move relative to extracellular matrix.
Interactions between ITGB1 and ADAM9 have already been
noted (see section on ADAM9). Integrins bind many proteins on
the cytoplasmic side of the membrane and bind matrix proteins on
the extracellular side [60]. Interactions on either side affect
interactions on the other side (inside-out and outside-in signaling).
Integrins also serve as mechanical connector between ECM and
cytoskeleton. The mechanical and signaling pattern on the
cytoplasmic side can switch between different binding partner
arrangements that can link directly or indirectly to the integrins
[60].
CD151, a HCCS24 gene (Figure 3), encodes a tetraspanin
transmembrane protein that binds integrins, such as ITGA3-
ITGB1 (Figure 12, interaction 19), and facilitated cell migration
[61]. CD151 promotes tumor cell motility, invasion and metastasis
of several clinical cancers. The enhanced mobility of hepatic
carcinoma cells was dependent on CD151-ITB1 interaction [62].
CD151 binds directly to ITGB1 and ITGA3, and the complex
binds indirectly to THSB1 (thrombospondin), a HCCS24 gene
product (Figure 3) [62] (see section on THSB1 below). An
extracellular region of CD151 binds a membrane-proximal
ectodomain of ITGA3. The structural factors involved in this
action were recently analyzed with the view of potential
development of therapeutic strategies whereby cell migration
could be inhibited while leaving stable cell attachments intact [61].
Expression of CD151 was found to correlate with expression of
MMP9, and both correlated with poor prognosis in hepatocellular
carcinoma [63].
LOXL2, a HCCS24 gene (Figure 3), encodes a secreted
copper-dependent lysyl oxidase that crosslinks collagen and elastin
[64]. LOXL2 promotes tumor cell invasion and is associated with
metastasis and reduced survival of patients with various cancers.
Its expression in tumor cells or tissues is associated with MMP9
and with another matrix metalloproteinase, TIMP1. Crosslinking
of collagen by LOXL2 may stimulate matrix metalloproteinases
such as MMP9 and TIMP1 to implement ECM remodeling
(Figure 9, interaction 20), thereby facilitating tumor cell migration
[64]. LOXL2 is a direct transcription target of HIF1A [65],
whereby it is up-regulated in response to hypoxia (interaction 21). If
VHL (Von Hippel-Lindau gene) is defective, HIF1A and LOXL2
are expressed even in normoxia [65].
AMOTL2 (angiomotin-like 2), encoded by a HCCS24 gene
(Figure 3), down-regulates YAP1 [66] (interaction 22), which is
a transcription co-activator of AXL [67] (interaction 23). AMOTL2
may suppress an epithelial-mesenchymal transition promoted by
YAP1.
EGFR (epidermal growth factor receptor) was one of the most
prominent HCCS24 genes (Figure 3); it correlated unusually
strongly with the expressions of ADAM9, AXL, and ITGB1
(expression profile correlations 0.76–0.78), in accord with findings
that EGFR interacts with a variety of integrins [59] (Figure 12,
interaction 24). EGFR and integrin each have the ability to affect the
downstream actions of the other, although the pathway details
have not been clarified. Beta1-integrins can promote EGFR-
dependent cell proliferation stimuli and might be developed as
a therapeutic target [68]. ADAM9 can cleave the precursor of
EGFR ligand NRG1 on the surface of an adjacent cell to release
NRG1 into the extracellular space, where it can bind and activate
EGFR [40] (interactions 25–27).
THBS1 (thrombospondin) is a disulfate-linked glycoprotein
involved in cell-to-cell and cell-to-matrix communications. It is
associated with ECM and interacts with a variety of plasma
membrane proteins, including some beta-1 integrins (Figure 12,
interactions 28 and 29). It may modulate ECM-integrin association
[69], either enhancing or weakening local cell-ECM attachments,
thereby allowing cells to be mobile [70]. THBS1 binds CALR
(calreticulin) in a Ca(2
+) or Zn(2
+) dependent manner, as
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disrupted [71–74] (interaction 30).
The THBS1 promoter has 3 AP-1 sites, suggesting that the gene
could be stimulated by a complex of JUN and a FOS-family
protein, perhaps including FOSL2 (interaction 31). Indeed, THBS1
transcription was activated by phosphorylation of JUN by
MAPK8/JNK1 [75]. That could account for the highly correlated
expression of THBS1 with JUN and FOSL2 (expression profile
correlations 0.66 and 0.60, respectively; Figure 3). MAPK8/
JNK1-induced JUN phosphorylation is counteracted by phospha-
tase DUSP1 (interactions 32 and 33). JUN, FOSL2, and DUSP1 are
in HCCS24 (Figure 3), and the latter two genes are also in
HCCS15 (Figure 2).
THBS1 gene expression in the NCI-60 was highly correlated
with dermatan sulfate epimerase (DSE) and chondroitin sulfo-
transferase CHST3 (Figure S1). This is of interest, because
THBS1 can bind proteoglycans such as chondroitin, dermatan,
and heparan sulfates [76], and these are constituents of
extracellular matrix. These interactions will be discussed in
a forthcoming report.
THBS1 is expressed in the developing central nervous system
(CNS), promotes neurite outgrowth from cultured neurons, and is
implicated in the migration of neural precursor cells. [77].
Notably, THBS1 was strongly expressed in all 6 CNS cell lines
in the NCI-60 panel (Figure 4). Moreover, it is plausible that
neurite extension would employ some of the same molecular
interactions as cell migration.
MYH9 is a high cross-correlation HCCS15 gene (Figure 2) that
codes for the heavy chain of non-muscle myosin IIA. Mutations or
allelic variations of MYH9 are associated with platelet pathology
and defective podocyte function in renal glomeruli [78–79]. The
association with kidney disorders fits with a high expression of
MYH9 that we observed in the NCI-60 renal cancer lines
(Figure 4). The MYH9 gene expression profile was also strongly
correlated with the metastasis-related gene THBS1/thrombos-
pondin (expression profile correlation 0.67; Figure 3).
In the polarized migrating cell, myosin II accumulates in the
sides and rear, while F-actin tends to enrich in the front of the cell;
the two engage in coordinating forward extension and rear
retraction [80–81]. Myosin IIA may release adhesions at the rear
part of the migrating cell by relaxing adhesion-stabilizing stress
fibers [82]. An association between MYH9 and cell migration is
also suggested by the effect of microRNA let-7f, which down-
regulates MYH9 expression, as well as cell invasion and metastasis,
[83]. (Let-7f expression however did not correlate significantly
with the migration-associated HCCS15 genes in the NCI-60 cell
lines.)
AXL has been reported to interact with non-muscle myosin
heavy chain IIB (MHC-IIB) [84]. Since MYH9 codes for non-
muscle myosin heavy chain IIA and its expression correlated
exceptionally well with AXL (expression profile correlation 0.74;
Figure 2), we conjecture that AXL and MYH9 in myosin IIA may
associate with each other and function together to confer
movement to migrating tumor cells, particularly in the process
of rear retraction, for which myosin IIA is required in several cell
types [11] (Figure 12, interactions 34 and 35).
Gene expression related to migration, mesenchymal, and
epithelial characteristics
The epithelial-to-mesenchymal transition (EMT) is character-
ized by increased expression of VIM (vimentin) and decreased
expression of E-cadherin (CDH1) [85]. Thus VIM is commonly
taken as a marker of mesenchymal and CDH1 of epithelial
character. Accordingly, nearly all of the NCI-60 cell lines exhibit
an inverse relationship between the expression of VIM and
CDH1, indicating which lines are epithelial, mesenchymal, or
indeterminate (Figure 6C). These distinctions can also be seen in
the clustered image map (CIM) in Figure 4. The cell lines that
strongly express the high cross-correlation genes associated with
cell migration (HCCS24; Figure 3) are all in clusters D, E1, or E2
in the CIM (Figure 4). Most of these cell lines express VIM more
strongly than CDH1 and therefore presumably have mesenchymal
character. In cluster A, we see the cell lines that express the
migration-related genes only weakly. Most of these lines express
CDH1 more strongly than VIM and therefore presumably have
epithelial character. Within this cluster, however, most of the
melanoma lines express VIM more strongly than CDH1, despite
their low expression of migration-related genes. It seems therefore
that melanoma cells may often have mesenchymal properties while
lacking the cell migration mechanisms commonly employed by
other solid tumors.
Ovarian carcinoma cell line OVCAR4 was unusual in having
high expression of both CDH1 and VCL (figure 4, arrow). (VCL
expression correlated well with both mesechymal and cell
migration related genes.) OVCAR4 therefore may have epithelial
character and engage in cell-cell junction activity enhanced by
VCL binding alpha and/or beta catenin, producing the bridge
CDH1-catenin-VCL-actin [35]. OVCAR4 showed high expres-
sion also of AMOTL2 and COL4A1 (Figure 4, arrow), suggesting
high potential for collagen production (Figure 12).
The gene expression profile of AXL, which is at the top of the
list of migration-related gene (Figure 3), was remarkably similar to
that of the mesenchymal marker genes VIM and SNAI2 (Slug),
with some exceptions, most notably by melanoma lines that
strongly expressed VIM and SNAI2, but not AXL (Figure 6D).
AXL and VIM are up-regulated together in migrating cells at
monolayer wound edges and in breast carcinomas [86]. VIM and
SNAI2 were highly expressed together with AXL in breast cancer
cell lines MDA_MB_231, HS578T, and BT_549, for example,
and may confer mesenchymal-like character to these lines
(Figure 6D).
Cluster B near the center of the CIM is made up largely by
leukemia lines (Figure 4), which exhibit low expression of both
VIM and CDH1 and very low expression of most of the
migration-related genes.
The gene-gene expression correlations are shown in the CIM in
Figure 5. The high cross-correlations of the HCCS24 genes (upper
24 genes in Figure 3) are evident in the almost uniformly red area
enclosed in the blue box in Figure 5. Of interest here is that some
genes, such as RAC1 and GAS6, that were not sufficiently cross-
correlated to be included in HCCS24 nevertheless correlated
significantly with many of those HCCS24 genes. Only FURIN
and FAM38A failed to correlate well with the entire set. For
FURIN, that is attributable to its functioning in adjacent stromal
cells rather than the tumor cells (Figure 12).
Comparison between NCI-60 cell migration-related
genes and EMT-upregulated genes in NSCLC cell lines
[87]
Cell migration requires the coordinated function of several
processes, only a few of which were described above. For epithelial
cells to migrate, they must first undergo an epithelial-mesenchymal
transition (EMT) involving molecular changes that have recently
been characterized by transcriptional and proteomic analysis by
Thomson et al [87]. Of approximately 50 genes/proteins that they
found to be up-regulated during EMT in genetically engineered
NSCLC cells, FLNA, THBS1, ITGB1, and LOXL2 were in our
HCCS24 high cross-correlation set (Figure 3); in addition, TPM1
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number of genes co-existing in both gene sets is presumably due to
the major differences in the systems and methods employed. It
probably reflects the large number of different systems that
participate in various aspects of cell migration.
To show the relationship between the EMT-upregulated genes
of Thomson et al and the cell migration-related genes listed in
Figure 3, we prepared a clustered image map of the NCI-60 gene
expression cross-correlations between those two sets of genes
(Figure 13). We see that the EMT-upregulated genes divided into
clusters, depending on how well they correlated with the NCI-60
gene migration-related gene set of Figure 3.
We also prepared a clustered image map of the expression of the
EMT-upregulated genes in the NCI-60 cell lines (Figure 14). We
see a marked dependence on cell type: epithelial (CO=colon,
breast T47D and MCF7; LE=leukemia; ME=melanoma). The
upper cluster contains mesenchymal-like cell lines, based on high
VIM/CDH1 expression (the epithelial-like cell lines had high
CDH1/VIM expression ratios). (CDH1 was included to show
epithelial character.)
These findings illustrate the complexity of the EMT and cell
migration-related regulation networks that remain to be elucidat-
ed, and suggest that those networks relate to each other in
definable ways.
Discussion
Tissue invasion and metastasis require molecular perturbations
that give tumor cells the mobility to migrate inappropriately. This
is one of at least 10 sequential changes that must occur for most
solid tumors to become fully malignant [10]. Migration of
malignant cells seems to differ from most normal cells in a more
rapid turnover of focal adhesions and more effective proteolysis of
extracellular matrix [30].
Cell migration is controlled via an extensive and highly
connected network of interactions between integrins and cytoskel-
eton, as well as between integrins and the cell exterior. Thus the
migration of adherent cells involves a complex interplay between
structural changes and signaling. The very large number of
interacting molecules in these processes constitute an ‘adhesome’
that presumably provides both robustness and flexibility [60]. The
sheer size and complexity of this network however makes efforts to
understand it a daunting task. We have made the problem more
tractable by putting the spotlight on a limited area of the full
network by focusing on those molecules whose genes are
coexpressed in a particular set of cell lines. The consequent
molecular interaction maps (Figures 11 and 12) therefore describe
a defined part of the full migration-related network: they describe
cell migration processes occurring in certain cells under certain
circumstances (although precisely when those circumstances apply
remains to be determined).
The current study identified cell migration-related genes that
were correlated both in expression profiles and in molecular
interactions and that comprised networks that we portrayed as
molecular interaction maps (Figures 11 and 12). We explored the
premise that gene expression correlations at the mRNA level can
reflect gene function relationships within networks of molecular
interactions. From a set of genes that have correlated gene
expression profiles in the NCI-60 panel of human tumor cell lines,
together with published information on their (or their product’s)
molecular interactions, we generated network models of how those
interactions may lead to coherent function. It seems remarkable
how expression-correlated genes came together in interaction
networks of coherent function (Figures 11 and 12).
We began with 15 highly cross-correlated genes (HCCS15)
(Figure 2), which were a subset of a cluster of 83 expression-
correlated genes derived by Zeeberg et al [9] that were enriched in
Gene Ontology (GO) categories loosely related to cell motility
(Figure 1). We then used the HCCS15 genes as seeds to harvest
other genes whose expression profiles were highly correlated with
them. This procedure yielded a set of 66 cross-correlated
(HCCS66) (Figure S1), which we then surveyed for molecular
interactions and function reported or reviewed in current
literature. Most of the HCCS66 genes had reported interactions
or functions that related to several different aspects of cell
migration mechanisms and that could be depicted as molecular
interaction maps (MIMs) [12,13] (http://discover.nci.nih.gov/
mim/). Here we developed network models for the role of RRAS
and calcium (Figure 11), and for interactions between extracellular
matrix and the cell surface (Figure 12). These particular migration-
related functions implicated 24 genes (HCCS24), which are
a subset of the 66 genes in HCCS66. (HCCS66 includes genes
involved in other migration-related functions that may be the
subject of a subsequent report). Relevant information for each
gene is summarized in sections of text in the Results. We aimed to
relate the expression correlations with the molecular interactions
and functions in the greatest possible detail in accord with current
evidence and hypotheses. In addition, we noted function relation-
ships that may not have been previously noted, including evident,
unexpected relationships for further investigation.
The first question we addressed was whether a correlation of
gene expression could predict an unexpected function relationship.
We noted an unusually high expression correlation between the
HCCS15 genes RRAS and ITGB1 (beta1-integrin) (expression
profile 0.78) (Figures 2 and 6A). We initially did not know how
those genes could be functionally related. However, a literature
search for reports dealing with both genes retrieved a recent paper
that connected them. in regulation of integrin-actin linkage by
calcium efflux from endoplasmic reticulum [20]. The authors
proposed a model of how RRAS and ITGB1 function to regulate
the linkage between extracellular matrix (ECM) and the cell
surface. We depicted the proposed model as a MIM in Figure 8. A
key step in the model was activation of calpain by calcium, but it
has not been determined which of the calpains may be involved.
From the expression correlations of 11 calpain isoforms with the
HCCS15 genes, we inferred that the relevant isoform was
probably calpain-2 (CAPN2) (Figure 10).
We then built upon the model by adding relevant interactions of
genes from HCCS66 (see Methods), depicted as a MIM in Figure 11.
The network depicted in Figure 11 has 15 genes/products, of
which 9 (shown in red) were highly expression-correlated with
other migration-related genes and were included in HCCS24 (a
subset of HCCS66 comprised of the genes relevant to the current
coverage). This network, which has well-defined functions in cell
migration, thus is composed largely of expression-correlated genes.
The network is centered on the actions of RRAS and calcium on
the linkage between integrins and the actin cytoskeleton. The
integrated functions of the genes in this network (Figure 11) can be
summarized as follows. (The highly expression-correlated genes/
products are in bold in the text below; interaction details and
references are given under Results in the summaries for the
individual genes.)
RRAS, which can be activated by BCAR3, has several actions
in this network. First, it stimulates release of calcium from
endoplasmic reticulum (ER); if ER calcium is depleted, STIM1,
which senses calcium concentration in the ER, stimulates TRPC1
[31]. TRPC1 helps to open channels that allow calcium entry into
the cell. The elevated cytosolic calcium activates calpain CAPN2
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RRAS is recruited by filamin FLNA to integrin ITGB1 and the
actin cytoskeleton to enhance the binding of integrin to
extracellular matrix (ECM). Third, RRAS may assist in temporary
endocytosis of integrins, a process that could function coopera-
tively in the adhesion/de-adhesion cycle. Finally, RRAS acts via
the RAC1 pathway to stimulate the production of cell surface
structures that interact with ECM and promote cell mobility.
We further extended the picture by adding another HCCS24-
based network of the regulation of ECM-cell surface attachments,
depicted as a MIM in Figure 12. This network involves 26 genes/
products, 17 of which had high expression cross-correlations and
are included in HCCS24. The focus of this network is degradation
Figure 13. Relationship between cell migration-related genes in this report with EMT-upregulated genes reported by Thomson
et al [87]: Clustered image map (CIM) of the cell migration-related genes (horizontal) listed in Figure 3 versus the EMT-upregulated
genes (vertical) reported by Thomson et al (reddish color in their Figure 3). This CIM depicts the expression correlations between the
respective genes in the NCI-60 cell line panel.
doi:10.1371/journal.pone.0035716.g013
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attachments between cell surface and ECM are disrupted. The
MIM shows how this ECM degradation process may be
coordinated though the actions AXL, ADAM9, and
TNFRSF12A/FN14. AXL and ADAM9 up-regulate matrix
metalloproteinases via the ERK pathway, while AXL and
TNFRSF12A/FN14 do so via the NFkB pathway. MMPs then
degrade ECM, so as to weaken the attachment of cells to
substratum, thereby freeing cells to migrate.
ECM degradation in the tumor environment, however, may be
due largely to MMPs secreted by neighboring fibroblasts rather
than by the tumor cells themselves [88]. Figure 12 outlines some
pathways whereby this may occur. The activation of MMP
transcription by NFkB may be promoted when AXL on the cell
surface binds its extracellular ligand, GAS6. Alternatively, this
activation may be promoted when FN14 (a product of the
TNFRSF12A gene) on the cell surface binds TWEAK on the
surface of an adjoining cell. This intercellular promotion activity
could occur in either direction between tumor and stromal cell.
Thus the inter-cellular interactions of AXL, FN14, and ADAM9
may be important in regulation of coupling between tumor and
stromal cells.
We think it remarkable that the coherent network models that
are portrayed as molecular interaction maps in Figures 11 and 12
consist largely of genes (or gene products) whose expression
profiles are highly cross-correlated over diverse cell lines
(Figures 3–5). The network model in Figure 12 depicts controls
on 3 events required for cells to be able to migrate: degradation of
extracellular matrix, production of focal complexes at the leading
edge of the cell, and retraction of the rear part of the cell. Figure 11
depicts controls on Ca (2
+), which may govern those events in
a spacio-temporally localized manner in the cell [23,89].
The highly cross-correlated genes we have discussed and
mapped are expression correlated more highly with VIM
Figure 14. Relationship between cell migration-related genes in this report with EMT-upregulated genes reported by Thomson
et al [87]: CIM of the expression of the EMT-upregulated genes in the NCI-60 cell line panel.
doi:10.1371/journal.pone.0035716.g014
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tend to convey mesenchymal rather than epithelial character.
That inference however applies only to those cell lines (the
majority) that show an inverse expression: VIM high, CDH1 low
(Figure 5); it does not apply to the leukemia lines nor to at least 2 of
the melanoma lines (Figure 6C), for which no clear epithelial/
mesenchymal assignment can be made based on CDH1/VIM
ratio. This distinctive gene expression character of the leukemia
lines is also evident in the clustered image map Figure 4. The close
alignment of the high cross-correlation (HCCS24) genes with
mesenchymal character is consistent with the functional interac-
tions of these genes with extracellular matrix and stroma
(Figures 11 and 12). In particular, the genes ADAM9, AXL, and
TNFRSF12A may connect directly between mesenchymal tumor
cells and stromal cells (Figure 12).
In conclusion, our findings on genes related to cell migration
suggest how expression correlations can yield clues to molecular
network functions. The results confirm many expected function
relationships and, perhaps more importantly, suggest unexpected
relationships for experimental investigation. Although mRNA
assays may be imperfect indicators of expression at the protein
level, we found that mRNA expression profiles by themselves did
give substantial information about the role of corresponding
proteins in interaction networks related to cell migration. More
definitive results may be obtained with new technology, such as
large-scale sequencing of ribosome-mRNA footprints [90,91].
Although we found that genes having correlated expression
profiles across a variety of human tumor cell lines tended to
function together in the same molecular interaction network, the
mechanism of the co-regulation remains to be elucidated.
Supporting Information
Figure S1 Extended high cross-correlation gene set
HCCS66. These 66 genes were selected on the basis of correlated
expression with the HCCS15 genes of Figure 2 (see Methods). The
gene names highlighted in yellow are the genes represented in the
molecular interaction maps (Figures 11 and 12). (MIM symbol
definitions are summarized in Figure 9.)
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